Skip to main content
OpenTrials

Clinical trial condition

Constipation Predominant Irritable Bowel Syndrome

Explore clinical trials studying Constipation Predominant Irritable Bowel Syndrome. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Constipation Predominant Irritable Bowel Syndrome trial results

Completed

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C

NCT02686138

Conditions
Constipation Predominant Irritable Bowel Syndrome
Locations
  • Ardelyx Investigative Site 257 Dothan, Alabama, United States
  • Ardelyx Investigative Site 200 Foley, Alabama, United States
  • Ardelyx Investigative Site 103 Huntsville, Alabama, United States
  • Ardelyx Investigative Site 244 Huntsville, Alabama, United States
View all 117 locations
View Trial Details
Completed

A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C

NCT02621892

Conditions
Constipation Predominant Irritable Bowel Syndrome
Locations
  • Ardelyx Investigative Site 149 Birmingham, Alabama, United States
  • Ardelyx Investigative Site 114 Birmingham, Alabama, United States
  • Ardelyx Investigative Site 103 Huntsville, Alabama, United States
  • Ardelyx Investigative Site 100 Huntsville, Alabama, United States
View all 111 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)

NCT01340053

Conditions
Constipation Predominant Irritable Bowel Syndrome
Locations
  • Ardelyx Investigational Site San Diego, California, United States
  • Ardelyx Investigational Site Jupiter, Florida, United States
  • Ardelyx Investigational Site Pinellas Park, Florida, United States
  • Ardelyx Investigational Site Rockford, Illinois, United States
View all 16 locations
View Trial Details

Related conditions